Gene therapy and peripheral nerve repair: a perspective

Clinical phase I/II studies have demonstrated the safety of gene therapy for a variety of central nervous system disorders, including Canavan’s, Parkinson’s (PD) and Alzheimer’s disease (AD), retinal diseases and pain. The majority of gene therapy studies in the CNS have used adeno-associated viral...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoyng, Stefan A., de Winter, Fred, Tannemaat, Martijn R., Blits, Bas, Malessy, Martijn J. A., Verhaagen, Joost
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502351/
https://www.ncbi.nlm.nih.gov/pubmed/26236188
http://dx.doi.org/10.3389/fnmol.2015.00032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502351/
https://www.ncbi.nlm.nih.gov/pubmed/26236188
http://dx.doi.org/10.3389/fnmol.2015.00032

Ejemplares similares